Revenue: The sum of all revenue fields included for a company's operating activities.
Assembly Biosciences, Inc. (ASMB) had Revenue of $7.16M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$7.16M |
$-61.23M |
|
-- |
|
$7.16M |
|
$71.81M |
|
$-64.65M |
|
$3.45M |
|
$-61.20M |
|
$-61.20M |
|
$-61.23M |
|
$-61.23M |
|
$-61.23M |
|
$-61.23M |
|
$-64.65M |
|
$-65.78M |
|
4.58M |
|
4.58M |
|
$-13.38 |
|
$-13.38 |
|
| Balance Sheet Financials | |
$133.79M |
|
$0.39M |
|
$3.04M |
|
$136.82M |
|
$39.23M |
|
-- |
|
$56.50M |
|
$95.73M |
|
$41.10M |
|
$41.10M |
|
$41.10M |
|
5.48M |
|
| Cash Flow Statement Financials | |
$22.74M |
|
$-69.14M |
|
$13.82M |
|
$52.42M |
|
$19.84M |
|
$-32.58M |
|
$5.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-902.50% |
|
-902.50% |
|
-918.34% |
|
-854.32% |
|
-854.78% |
|
$22.51M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
166.58 |
|
2.19 |
|
-148.98% |
|
-148.98% |
|
-44.75% |
|
-148.98% |
|
$7.50 |
|
$4.92 |
|
$4.97 |
|